CTOs on the Move

EyePoint Pharmaceuticals

www.eyepointpharma.com

 
EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
David Vario
 Vice President Of Quality Profile
Said Saim
 Chief Technology Officer Profile

Funding

EyePoint Pharmaceuticals raised $29M on 10/02/2018
EyePoint Pharmaceuticals raised $15.7M on 01/03/2021
EyePoint Pharmaceuticals raised $45M on 03/09/2022

Similar Companies

Genysis

Genysis Brand Solutions is a customer-centric, turn-key powder and capsule manufacturer.

Tower Health

Tower Health brings together more than 11,000 team members, 2,000 nationally recognized physicians, specialists and providers across 65 convenient locations.

Cenduit

Cenduit is the leading IRT systems specialist in the world, with rapid study startup software, clinical supply chain intelligence, clinical operations know-how and customer-centric CORE teams making sure your study starts quickly and runs smoothly. Other IRT-driven services include patient randomization and trial supply management (RTSM), integration, patient engagement and materials forecasting. We have over 500 experts worldwide in the US, UK, Switzerland, India, Japan and China, with clinical trial experience in more than 100 countries, interacting with more than 600,000 patients at more than 32,000 sites. Let Cenduit`s experts ensure that your study needs are met on time and within budget.

Den-Mat Holdings, LLC.

Den-Mat Corp has also developed revolutionary LUMINEERS BY CERINATE, the first porcelain laminates that are contact lens-thin and strong, eliminating the need for the shaving and grinding down of sensitive tooth structure.

Alzyn

ALZYN is a development stage company pursuing a unique approach to retard the progress of Alzheimer`s Disease. The science originated at the Florida State University`s College of Medicine.